ETF Battles ARKG vs. GNOM - What's the better genomic/biotech play?
Listen now
Description
Are you ready to go to rumble? In this episode of ETF Battles you'll see a clash between the ARK Genomics Revolution ETF (ARKG) vs. the Global X Genomics & Biotechnology ETF (GNOM). Which ETF is the better play? Ron DeLegge @ETFguide referees the matchup with guest judges Cinthia Murphy at ETF.com and Dave Kreinces at ETF Portfolio Management providing their research insights.  Each ETF is judged against the other in key categories like cost, exposure strategy, performance and a mystery category. Find out who wins the battle! 
More Episodes
In this Season 5 episode of ETF Battles, Ron DeLegge @etfguide referees a cryptocurrency showdown between the Grayscale Ethereum Trust (ETHE),  Grayscale Digital Large Cap Fund (GDLC) and iShares Bitcoin ETF (IBIT). Which crypto ETP wins this triple header? Program judges David Kreinces and...
Published 03/20/24
Published 03/20/24
In this Season 5 episode of ETF Battles, Ron DeLegge @etfguide referees an technology and semiconductor equity ETF showdown between Invesco (QQQ), State Street Global Advisors (XLK) and Van Eck (SMH). Which ETF wins this tech heavy triple header? Program judges David Kreinces and Shana Sissel...
Published 03/09/24